During the past decade, Affinity Health conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affinity Health" #1 sponsor was "Pfizer" with 2 trials, followed by "Sucampo Pharma Americas, LLC" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Achieve Life Sciences" with 1 trials sponsored and "Axsome Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affinity Health" #1 collaborator was "CureVac" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator, "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Affinity Health" are "Osteoarthritis, Knee" (4 trials), "Knee Osteoarthritis" (3 trials), "Opioid-Induced Bowel Dysfunction" (2 trials), "Osteoarthritis, Hip" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Affinity Health" in a lesser frequency.

Most popular intervention types in "Affinity Health" are "Drug" (14 trials), "Biological" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ACP-044 Dose A" (1 trials), "ACP-044 Dose B" (1 trials), "AXS-02" (1 trials) and "Amniotic Suspension Allograft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affinity Health" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Affinity Health". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Affinity Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Affinity Health, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".